课题基金 / 基金详情

TREATMENT OF KAWASAKI DISEASE--PULSE IV METHYLPREDNISOLONE VS IVIG

TREATMENT OF KAWASAKI DISEASE--PULSE IV METHYLPREDNISOLONE VS IVIG
川崎病的治疗--PULSE IV甲泼尼龙VS IVIG
批准号:
6281435
负责人:
ROBERT SUNDEL
金额:
$2.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30

项目摘要

项目成果

ROBERT SUNDEL的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Children diagnosed with Kawasaki disease prior to the eighth day of fever will be randomized to receive traditional therapy, intravenous immunoglobulin (IVIG) 2 g/kg over 8-12 hours, or experimental therapy, intravenous methyprednisolone (IVMP), 30 mg/kg in D5W over 2 hours on each of two consecutive days. All children will otherwise receive treatment according to current standards of care. Any child receiving either IVIG or IVMP therapy who is febrile 48 hours after treatment will receive IVIG (salvage therapy), according to current treatment guidelines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Blood cell activity in Kawasaki Disease
  • 批准号:
    6975180
  • 项目类别:
  • 资助金额:
    $0.74万
  • 财政年份:
    2004
  • 负责人:
    ROBERT SUNDEL
  • 依托单位:
THE PREVALENCE AND CLINICAL CHARACTERISTICS OF CYSTIC FIBROSIS ARTHROPATHY
  • 批准号:
    6120776
  • 项目类别:
  • 资助金额:
    $3.04万
  • 财政年份:
    1998
  • 负责人:
    ROBERT SUNDEL
  • 依托单位:
THE PREVALENCE AND CLINICAL CHARACTERISTICS OF CYSTIC FIBROSIS ARTHROPATHY
  • 批准号:
    6220556
  • 项目类别:
  • 资助金额:
    $0.07万
  • 财政年份:
    1998
  • 负责人:
    ROBERT SUNDEL
  • 依托单位:
TREATMENT OF KAWASAKI DISEASE--PULSE IV METHYLPREDNISOLONE VS IVIG
  • 批准号:
    6120816
  • 项目类别:
  • 资助金额:
    $3.04万
  • 财政年份:
    1998
  • 负责人:
    ROBERT SUNDEL
  • 依托单位: